logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > DESONIDE CAS 638-94-8

DESONIDE CAS 638-94-8

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 638-94-8

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Bag,Drum

Delivery Time: 7-15 days

Payment Terms: L/C, D/A, T/T, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
638-94-8
Appearance::
White To White Like Solid
Molecular Formula::
C24H32O6
Molecular Weight::
416.50700
EINECS NO::
211-351-6
MDL NO::
MFCD00866151
CAS NO::
638-94-8
Appearance::
White To White Like Solid
Molecular Formula::
C24H32O6
Molecular Weight::
416.50700
EINECS NO::
211-351-6
MDL NO::
MFCD00866151
DESONIDE CAS 638-94-8

Product Description:

Product Name: DESONIDE CAS NO: 638-94-8

 

 

Synonyms:

(11b,16a)-11,21-dihydroxy-16,17-((1-methylethylidene)bis(oxy))-pregna-1,4-diene-3,20-dione;16-alpha-hydroxyprednisole-16,17-acetonide;

17-acetonide,16-alpha-hydroxy-prednisolone-1;

 

 

Chemical & Physical Properties:

Appearance:White to white like solid

Assay :≥99.0%

Density: 1.3 g/cm3

Boiling Point: 580.1℃ at 760 mmHg

Melting Point: 274 – 275℃

Flash Point: 196.9℃

Refractive Index: 1.598

Storage Condition: Refrigerator

 

 

Safety Information:

HS Code: 2937210000

 

 

Anti-inflammatory. Desonide has also been found as an impurity in budesonide. Desonide is a nonfluorinated corticostero-id anti-inflammatory agent used topically for dermatoses.Target: Glucocorticoid ReceptorDesonide is a low-potency topical corticostero-id that has been used for decades in the treatment of stero-id-responsive dermatoses. Desonide induced significant colorimetric improvement compared with placebo. A good to excellent response was achieved in 30% for desonide, and 6% for placebo. Decreased pigmentation in the desonide-treated axillae was associated with recovery of disruption at the basal membrane. Desonide showed depigmenting properties in women with axillary hyperpigmentation. Given the favorable safety profile of all other desonide preparations and their utility as a low potency corticostero-id, desonide foam promises to be a useful addition to the armamentarium, when other desonide vehicles might be less acceptable.

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.